{"id":"NCT01193244","sponsor":"Millennium Pharmaceuticals, Inc.","briefTitle":"Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer","officialTitle":"A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel Plus Prednisone With Placebo Plus Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-10-01","primaryCompletion":"2014-01-01","completion":"2016-04-07","firstPosted":"2010-09-01","resultsPosted":"2017-05-17","lastUpdate":"2017-05-17"},"enrollment":1560,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Orteronel","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Prednisone","otherNames":[]}],"arms":[{"label":"Orteronel + prednisone","type":"EXPERIMENTAL"},{"label":"Placebo + prednisone","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, multicenter, phase 3 study evaluating orteronel (TAK-700) plus prednisone compared with placebo plus prednisone in the treatment of men with progressive, chemotherapy-naive, metastatic, castration-resistant prostate cancer (mCRPC)","primaryOutcome":{"measure":"Radiographic Progression-free Survival (rPFS)","timeFrame":"Baseline until radiographic disease progression or death, whichever occurred first (approximately up to 4.7 years)","effectByArm":[{"arm":"Placebo + Prednisone 5 mg","deltaMin":8.7,"sd":null},{"arm":"Orteronel 400 mg + Prednisone 5 mg","deltaMin":13.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.00001"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":240,"countries":["United States","Australia","Austria","Belarus","Belgium","Brazil","Bulgaria","Canada","Chile","Colombia","Czechia","Finland","France","Germany","Greece","Hong Kong","Ireland","Israel","Italy","Japan","Latvia","Lithuania","Mexico","Netherlands","New Zealand","Peru","Poland","Portugal","Puerto Rico","Romania","Russia","Singapore","Slovakia","South Africa","Spain","Sweden","Switzerland","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":["29272162","26031410","25701170"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":321,"n":770},"commonTop":["Fatigue","Nausea","Constipation","Back pain","Diarrhoea"]}}